- Randomized noninferiority trial of 114 patients scheduled for anterior cruciate ligament repair at one Toronto hospital, using a fabricated low-risk research trial with active deception.
- Patients were invited to the fabricated trial either at a virtual preanesthesia visit in advance or on the day of surgery.
- Participation in the fabricated trial was 45% (26/58) for same-day consent versus 30% (17/56) for advance consent, and perceived coercion did not differ between groups.
- The authors conclude that same-day consent restrictions based on undue influence concerns may be a structural barrier to low-risk trial participation without empirical support.
Perioperative medicine
Research from anesthesiology, pain and critical care journals, sourced from PubMed.
Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.
AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.
Last successful paper check: 16 Nov 2026 17:18 UTC.
0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
- Single-center, patient- and assessor-blinded randomized trial of 192 women undergoing elective gynecological laparoscopic surgery, with 364 assessed.
- Participants wore passive noise-attenuating earmuffs from induction to end of surgery or received usual care, and all received dexamethasone and palonosetron.
- PONV within 48 hours occurred in 35.4% with noise isolation versus 52.1% with control (adjusted risk difference -0.179, 95% CI -0.318 to -0.040; P = 0.012).
- Authors conclude noise isolation was associated with lower PONV incidence and severity; secondary endpoints favored it after FDR correction, but adverse events and recovery quality did not differ.
- Multicentre randomised trial of 400 children aged 2 to under 7 years undergoing adenotonsillectomy at four tertiary hospitals in China.
- Children were randomised 1:1 to ventilation with a laryngeal mask airway or an endotracheal tube.
- Any perioperative respiratory adverse event occurred in 22.5% of the LMA group versus 57.5% of the ETT group (absolute risk difference -35.0 points, 95% CI -43.5 to -25.7; P<0.001).
- The authors conclude that LMA ventilation by experienced anaesthesiologists produced fewer respiratory adverse events, and neither group had serious adverse events.
- Randomized, double-blind dose-finding trial of 99 children aged 1-6 years undergoing adenotonsillectomy, with a glucose control group.
- Children received oral 10% glucose or oral esketamine at 1, 2, or 3 mg/kg, given 30 minutes before anesthesia.
- At cannulation, all esketamine doses improved sedation and analgesia (overall p < 0.001), greatest at 3 mg/kg, where median FLACC was 0.00 versus 6.00 in controls.
- The authors favored 2 mg/kg for balancing efficacy and safety, and 3 mg/kg for superior analgesia and opioid sparing (remifentanil 120 vs 240 μg, p = 0.001).
- Multicentre, randomised, double-blind trial in 873 analysed adults (914 randomised) undergoing video-assisted thoracoscopic lung resection.
- Perioperative low-dose esketamine (bolus at induction, then intra- and postoperative infusion for 48 h) was compared with normal saline.
- Chronic pain at 3 months was 14.7% with esketamine versus 21.2% with control (adjusted OR 0.62, 95% CI 0.43-0.90; P=0.013).
- A post hoc definition using NRS ≥3 during coughing also favoured esketamine (adjusted OR 0.39, 95% CI 0.19-0.84; P=0.015), and the authors report no increase in adverse effects.
- Randomized, double-blind, placebo-controlled single-center trial of 70 patients undergoing on-pump CABG.
- Patients received intranasal dexmedetomidine 1 μg/kg or saline on the night before surgery and again 30 minutes before induction.
- At 24 hours, estimated marginal mean hs-cTnT was 170.29 vs 357.29 ng/L (P < 0.001) favoring dexmedetomidine; CK-MB was also lower.
- Sleep quality scores were higher and postoperative delirium was lower (14.3% vs 37.1%; P = 0.029), but the authors call the findings preliminary.
- Protocol for a multicentre randomized controlled trial in patients aged 60 or older with anaemia (haemoglobin ≤90 g/l) undergoing surgery for hip fracture.
- Compares a liberal transfusion strategy (haemoglobin target 90 to 110 g/l) with a restrictive strategy (target 75 to 90 g/l) from randomization to discharge or 30 days.
- No efficacy results are reported; the primary outcome is a composite of death or major adverse cardiac events, adjudicated by blinded experts, with quality of life assessed at 120 days.
- The authors reduced the target sample size from 1,984 to 842 and added myocardial injury after non-cardiac surgery (MINS) to the primary outcome after recruitment fell short.
- Single-center, prospective cluster-randomized trial by month in cardiac surgery patients receiving intraoperative cryoprecipitate, stopped early at 170 of 502 planned patients.
- Pathogen-reduced cryoprecipitated fibrinogen complex (PR CRYO, storable at room temperature post-thaw) was compared with conventional cryoprecipitate (Cryo).
- Total blood components transfused were identical (6 units, IQR 3-12, p > 0.9), while PR CRYO was issued 19 min faster (12 vs. 31 min, p < 0.001) and transfusion began 16 min sooner (46 vs. 62 min, p = 0.008).
- No reduction in 30-day transfusions was shown, adverse events and 3-day transfusions were similar, and equivalence could not be formally concluded.
- Single-center randomized trial of 100 adults aged 65 or older with RAI-C scores above 15, undergoing elective gastrointestinal surgery in Shanghai.
- Participants were randomized 1:1 to fluid-responsiveness-guided preinduction volume optimization using passive leg raising and echocardiography, or usual care.
- Any MAP below 65 mmHg during postinduction minutes 1 to 15 occurred in 38% versus 72% (risk difference -34.0 points, 95% CI -50.1 to -14.5; relative risk 0.53, 95% CI 0.36 to 0.78; P = .001).
- The authors concluded that optimization reduced early postinduction hypotension, but noted that differences in hypotension depth and burden were modest.
- This prospective randomized trial enrolled 271 adults undergoing elective sternotomy at a single center, randomized 1:1:1 to standard therapy, ESP block, or SPIP block.
- Both fascial plane blocks were added to a multimodal analgesic regimen and compared with the control group receiving standard therapy alone.
- Opioid use did not differ significantly on postoperative days 0 to 2; a day 3 difference favored ESP (p = 0.047). Maximum pain scores were lower in both block groups on days 0 to 3 (POD 1 p < 0.001, POD 2 p < 0.001, POD 3 p = 0.002).
- The authors conclude that patients undergoing sternotomy may benefit from adding either ESP or SPIP blocks to a multimodal postoperative regimen.
- Multicenter randomized non-inferiority trial of 210 children under 2 years undergoing single-stage midshaft or distal hypospadias repair, with 161 completing 3-month follow-up.
- Children were randomized to caudal block (n=79 analyzed) or penile block (n=82 analyzed), both under general anesthesia.
- Urethrocutaneous fistula occurred in 8.9% of caudal and 7.3% of penile block patients (RR 0.98; 95% CI 0.35 to 2.76; p=0.9).
- Caudal block was associated with less intraoperative and rescue opioid use and lower PACU FLACC scores, though the authors call these findings exploratory given early termination and wide CIs.
- Randomized controlled trial of 60 children undergoing adenotonsillar surgery, allocated to methylprednisolone, dexamethasone, or no corticosteroid.
- Children received methylprednisolone 1 mg/kg, dexamethasone 0.2 mg/kg, or no steroid before sugammadex reversal of rocuronium block.
- Reversal time was longer with methylprednisolone (82.8 ± 16.1 s) than with dexamethasone (63.4 ± 13.4 s) or control (56.1 ± 13.7 s), p < 0.001.
- Extubation time followed a similar pattern, while postoperative pain, nausea, and adverse event rates did not differ significantly between groups.
- This delirium-focused secondary analysis of a single-centre, double-blind, placebo-controlled trial enrolled adults having head and neck cancer surgery with free-flap reconstruction.
- Patients received intraoperative dexmedetomidine at 0.3 μg/kg/h until 1 hour before surgery ended, or comparable volumes of saline placebo.
- Delirium over the first 5 postoperative days occurred in 14.9% (7/47) of dexmedetomidine patients versus 34.7% (17/49) of placebo patients (adjusted OR 0.31, 95% CI 0.10-0.92; p = 0.036).
- Pain and early sleep were reported as improved with dexmedetomidine, and haemodynamic adverse events and postoperative complications did not differ significantly between groups.
- Multicenter, double-blind, placebo-controlled randomized trial in 1210 patients (1188 analyzed at day 30) undergoing elective curative-intent digestive cancer surgery across 23 French hospitals.
- Patients received 20 mg/kg intravenous methylprednisolone at anesthesia induction or an identical-appearing placebo.
- Major postoperative complications within 30 days did not differ significantly: 23% (139/594) with methylprednisolone vs 20% (119/594) with placebo; P = .16.
- Secondary outcomes, including postoperative infections (P = .75), intra-abdominal infections (P = .27), wound healing problems (P = .13) and length of stay (P = .93), also showed no difference; the authors advise against routine use.
- A registry-based cross-sectional study of 74 adult interventional regional anesthesia trials initiated 2017-2024 that had posted results and linked publications on ClinicalTrials.gov.
- The authors compared the earliest and most recent registry versions of each trial's outcome fields to identify changes in outcome definitions, timing, and classifications.
- 91.9% of trials had at least one substantive outcome change, and 37.8% had high-impact modifications. The latest substantive change came after primary completion in 47.1% and after publication in 51.5%.
- None of these latest modifications were disclosed, and secondary outcomes were added or removed more often than primary outcomes.
- Pragmatic, open-label, multicenter randomized trial of 2508 adults aged 50 or older having elective major noncardiac surgery at 49 UK NHS hospitals.
- Patients were randomized 1:1 to maintenance of general anesthesia with propofol TIVA or volatile inhalational agents, with other perioperative care left to clinician discretion.
- Days alive and at home at 30 days were similar (22.5 vs 22.4 days; incidence rate ratio 1.00, 95% CI 0.99-1.02; adjusted P = .68).
- TIVA was associated with lower reported thirst, hoarseness, and nausea/vomiting; major complications (12.4% overall) did not differ between groups.
- Prospective randomized controlled trial of 254 children aged 3-9 years undergoing elective adenotonsillectomy.
- Children were intubated with a room-temperature polyvinyl chloride endotracheal tube or one softened and pre-warmed to 37°C.
- Overall perioperative respiratory adverse events were 14.1% with warmed tubes versus 24.6% with room-temperature tubes (p = 0.039), with lower laryngospasm and postoperative coughing.
- Room-temperature tube use was an independent predictor (adjusted OR 2.29, 95% CI 1.16-4.54); the authors call for multicenter confirmation.
- A preplanned secondary analysis of a single-center, double-blind, 3-arm randomized trial in 34 adults undergoing elective CABG with cardiopulmonary bypass.
- Patients received albumin-based, gelofusine-based, or retrograde autologous priming (reference), with Stewart acid-base variables measured at five perioperative time points.
- Bypass initiation caused metabolic acidosis (-0.1 pH, -4.3 mmol/L standard base excess, -6.6 mEq/L effective strong ion difference), and these measures did not differ among priming strategies.
- Each extra liter of crystalloid independently lowered pH (-0.011; p = 0.035) and effective strong ion difference (-1.03 mEq/L; p = 0.025), which the authors attribute to crystalloid load rather than colloid choice.
- Post hoc secondary analysis of two trials across 30 hospitals, including 1963 adults having major abdominal or thoracic surgery.
- Compared patients given antiemetic-dose intraoperative corticosteroids with those who did not, using inverse probability of treatment weighting for preoperative confounders.
- After weighting, steroids were not significantly associated with fewer postoperative pulmonary complications (OR 0.86, 95% CI 0.62-1.18, P=0.347), though the unweighted rates were lower (9.3% vs 14.0%).
- PACU PaO2/FiO2 ratio was modestly higher with steroids (adjusted mean difference 19.9 mm Hg, 95% CI 0.64-39.1, corrected P=0.043).
- Prospective, open-label randomized trial of 105 adults aged 60 or older with moderate renal insufficiency undergoing elective OPCAB, split equally into three groups.
- Dexmedetomidine 0.4 μg/kg/h without a loading dose and dopamine 3 μg/kg/min were each compared with a normal saline control, infused from induction through 24 postoperative hours.
- Dexmedetomidine raised urine output (p < 0.01) and eGFR (p < 0.0001) versus dopamine and control at days 1 and 2; creatinine and BUN differences were not clinically significant.
- No group developed AKI by AKIN criteria, adverse events were similar across groups (p = 0.31), and the authors conclude neither drug prevented AKI beyond control.
- International, double-blind, placebo-controlled randomised trial of 955 adults with anaemia awaiting elective cardiac surgery, across 33 hospitals in 10 countries.
- Participants were randomised to 1000 mg intravenous iron or placebo 1 to 26 weeks before surgery.
- Days alive and at home at 90 days were 81.1 with iron versus 80.0 with placebo (adjusted median difference 1.0 day, 95.4% CI 0.0 to 2.1, P=0.041).
- Transfusion during hospital stay was 61.1% with iron versus 68.2% with placebo (RR 0.90, 95% CI 0.82 to 0.99, P=0.027); complications and stay did not differ.
- Double-blind, placebo-controlled single-center randomized trial of 232 patients aged 60 or older, ASA 1 to 3, undergoing total hip or knee arthroplasty in China.
- Intranasal dexmedetomidine 100 μg versus normal saline given at 21:00 on the night before surgery.
- Delirium within 3 postoperative days occurred in 10.3% versus 20.7% (relative risk 0.50; 95% CI 0.26-0.95; P=0.030) in the intention-to-treat analysis.
- The authors report improved sleep quality and reduced anxiety and pain, with no severe adverse events or nasal mucosal injury, and suggest sleep improvement may partly explain the delirium reduction.
- Prespecified substudy of a single-center randomized trial in 134 randomized adults aged ≥50 undergoing elective CABG and/or valve surgery; 116 completed 3-month follow-up.
- Compared 4-6 weeks of multimodal prehabilitation (exercise, nutritional, and psychological support) with standard preoperative care, with POCD defined by tests 1.5 SD below norms.
- POCD occurred in 28% with prehabilitation vs 22% controls (OR 1.37, 95% CI 0.54-3.50, P = 0.52); preoperative cognitive impairment was strongly associated (OR 13.28).
- Authors conclude prehabilitation did not reduce POCD at 3 months, while higher postoperative physical activity was linked to lower odds (OR 0.97, 95% CI 0.95-1.00, P = 0.047).
- Post hoc analysis of a Japanese multicenter RCT in 339 adults aged 65 or older who survived septic shock to 90 days, from 513 eligible patients.
- Frailty at 90 days was graded by Clinical Frailty Scale, and associations with baseline characteristics and treatments were assessed by ordinal regression.
- Higher presepsis CFS (aOR 2.03 per point), higher SOFA (aOR 1.16 per point), and corticosteroid use (aOR 1.72) were each independently associated with more severe frailty.
- Corticosteroid use was linked to frailty mainly in patients already frail at baseline, while SOFA mattered most with lactate of 2 mmol/L or more.
- Prospective randomized physiologic study of 80 patients with early septic shock in one university hospital medical ICU.
- All patients first underwent a 2-hour MAP test (65-70, then 80-85 mm Hg) measuring renal resistive index, then were randomized to low or high MAP targets for 5 days.
- Twenty-three patients (29%) were RRI responders, and among them a higher MAP target did not improve renal outcomes such as diuresis, KDIGO stage, RRT need, or creatinine.
- Nonresponders had higher urine output with the high target, an exploratory finding suggesting that no RRI drop may flag patients who gain diuresis from a higher MAP.
- Secondary analysis of the SISPCT randomized trial, including 971 patients with admission plasma H3.1 data from 33 German ICUs.
- The exposure was admission plasma H3.1 nucleosome levels, and no intervention was assigned in this analysis.
- Each one log10 increase in H3.1 was associated with higher 28-day mortality (adjusted HR 1.48, 95% CI 1.07-2.04; p = 0.02).
- H3.1 levels were also associated with later renal replacement therapy (adjusted HR 1.8, 95% CI 1.34-2.40) and were higher in septic shock than in sepsis.
- Randomised non-inferiority trial of 455 patients aged 65 or older undergoing lung resection, with delirium assessed by blinded assessors.
- Remimazolam anaesthesia was compared with propofol anaesthesia for postoperative delirium during the first three postoperative days.
- Delirium occurred in 48% versus 31% of patients (RR 1.53, 95% CI 1.21-1.94), with a 16.5% absolute difference (95% CI 7.7-25.3%) that exceeded the 10% margin.
- Emergence delirium was more frequent with remimazolam (46% vs 28%), and the authors concluded remimazolam was not non-inferior to propofol.
- Randomized, open-label trial of 88 adults with new post-CPB right ventricular systolic dysfunction (TAPSE ≤17 mm) at a tertiary cardiac surgery center.
- Milrinone, given with a loading dose and then an infusion, was compared with a dobutamine infusion.
- TAPSE improved in both groups, and milrinone's adjusted 24-hour TAPSE advantage was 1.82 mm (95% CI 0.72-2.92, p = 0.001), of uncertain clinical significance.
- Milrinone required more norepinephrine (93.2% vs 72.7%, p = 0.021), and an exploratory subgroup with PASP >40 mmHg (n = 30) suggested greater TAPSE gain, a hypothesis-generating finding.
- Multicenter randomized trial at two Chinese hospitals enrolled 253 patients aged 60 or older undergoing non-cardiac surgery, randomized 1:1.
- Patients were assigned to POTTS-guided transfusion, a score built from adrenaline use, FiO2, temperature and angina history, or to control care following the 2012 AABB guideline.
- Transfusion was required in 24.00% (30/125) of POTTS patients versus 35.94% (46/128) of controls (p = 0.038), with no significant difference in transfusion volume.
- The authors concluded POTTS reduced the proportion transfused without increasing complications, though complication rates were 12.80% versus 8.59% (p = 0.279), not significantly different.
- Secondary analysis of the FIBRES randomized trial, including 735 adults with significant postbypass bleeding and hypofibrinogenemia across eleven Canadian hospitals.
- Fibrinogen concentrate (4 g) was compared with cryoprecipitate (10 units), dosed within 24 hours after cardiopulmonary bypass as needed.
- In non-critically ill patients, FC led to fewer cumulative blood components (mean ratio 0.84, 95% CI 0.73 to 0.96; p=0.01), with a similar pattern in elective surgery patients.
- In elective surgery patients, adverse events (RR 0.85) and serious adverse events (RR 0.71) were less frequent with FC, which the authors suggest may be a safety advantage.
AI summary not available. Read the source abstract on PubMed.
- Single-center, double-blind, placebo-controlled randomized trial of 160 adults undergoing thyroidectomy under general anesthesia.
- Participants received bilateral superficial cervical plexus blocks with 0.25% bupivacaine or saline, with all receiving multimodal analgesia.
- Quality of recovery (QoR-40) on postoperative day 1 did not differ: 174 versus 173, adjusted mean difference 0.91 (95% CI, -3.57 to 5.40; P = 0.688).
- The bupivacaine group used less PACU opioid (P = 0.017) and fewer needed rescue antiemetics (3 [3.8%] vs 13 [16%]; P = 0.011).
- This subgroup analysis of the MINT trial included 3504 adults with acute myocardial infarction and anemia across 144 sites, of whom 1679 (47.9%) were critically ill.
- Patients were randomized to a restrictive strategy (transfuse at hemoglobin below 7-8 g/dL) or a liberal strategy (below 10 g/dL), with 30-day outcomes compared by ICU status.
- The restrictive strategy showed nonsignificant increases in death in critically ill (RR 1.24; 95% CI 0.95-1.61) and noncritically ill patients (RR 1.09; 95% CI 0.77-1.54); interaction p = 0.55.
- Death and death/MI were more common in critically ill patients at 30 days, and the authors found no evidence that the overall liberal-favoring MINT results differ by ICU status.
- Randomized, blinded, two-center French superiority trial of 320 adults undergoing elective cardiac surgery with cardiopulmonary bypass.
- Patients received opioid-free anesthesia with ketamine, dexamethasone, lidocaine and magnesium, or opioid anesthesia with sufentanil.
- The 30-day composite of complications or death occurred in 75.4% versus 84.5% (RR 0.90; 95% CI 0.80 to 0.99; P = 0.049), with a fragility index of 1.
- The authors call the results hypothesis generating; cardiovascular and digestive complications and deaths were also lower with opioid-free anesthesia.
- Single-center, double-blind, placebo-controlled RCT of 384 women aged 18 to 50 undergoing ambulatory surgery under general anesthesia.
- Participants received oral 5 mg olanzapine or placebo, with both groups also receiving dexamethasone and ondansetron prophylaxis.
- Olanzapine raised QoR-40 scores on POD 1 by 9.0 points (95% CI, 6.1 to 11.8; P < 0.001).
- Olanzapine also lowered the odds of any nausea on POD 1 (OR 0.43) and POD 2 (OR 0.48), while PACU length of stay did not differ.
- Single-center, double-blind, placebo-controlled randomized trial of 70 adults with delayed recovery after on-pump cardiac surgery in Cairo, Egypt.
- Enteral levothyroxine (25-50 µg/d, titrated by body mass index) versus identical placebo, started on postoperative day 2 and continued until ICU discharge.
- The levothyroxine group had greater GCS improvement (aMD +7.81; 95% CI 5.24-10.38; p<0.001) and lower 30-day mortality (14.3% vs 45.7%; aHR 0.24; 95% CI 0.09-0.65; p=0.005).
- The authors call the mortality finding hypothesis-generating given only 21 events, and hospital stay was longer with levothyroxine (13.1 vs 10.3 days, p=0.005).
- Single-center randomized controlled study of 122 adults aged 60 or older with preoperative Anticholinergic Cognitive Burden scores of 3 or higher undergoing CABG.
- Patients given a deprescribing strategy that avoided perioperative anticholinergic anesthetic and analgesic drugs were compared with standard care that included them.
- At day 90, full Katz Index independence was more frequent with deprescribing (75.0% vs 41.1%, p < 0.001), and frailty scores were lower (median 3 vs 4, p < 0.001).
- Perioperative anticholinergic use was an independent predictor of 90-day total complications (OR 2.430, 95% CI 1.031-5.726, p = 0.042), and the authors call anticholinergic burden a modifiable risk factor.
- Predefined exploratory substudy of the GLORIOUS trial, including 878 adults undergoing nonemergent CABG and/or surgical aortic valve replacement at one tertiary center.
- Patients received restrictive (FiO2 50%) or liberal (FiO2 100%) oxygenation during bypass and the first hour after weaning; lung function was measured before and at 3 months.
- Pulmonary function fell across all measures at 3 months, such as FEV1 by 8.3 percentage points (95% CI 6.6 to 8.3), with no between-group differences (all p > 0.3).
- The authors concluded that restrictive oxygenation did not attenuate the decline and described the findings as hypothesis-generating.
- Double-blinded, placebo-controlled RCT at two Danish university hospitals, with 100 of 113 randomized patients undergoing non-emergent CABG analyzed.
- Surgeon-administered intraoperative sternal and chest wall infiltration with bupivacaine, epinephrine, clonidine, and dexamethasone (62.5 mL) was compared with saline placebo.
- No difference in opioid use over the first 24 postoperative hours: median 62.3 mg versus 64.0 mg oral morphine equivalents (p = 0.649).
- No secondary or safety endpoints differed significantly, and the authors concluded the intervention did not reduce opioid consumption or add clinical benefit.
- Open-label randomised controlled trial of 148 osteosynthesis patients at a university hospital, comparing a thermal care bundle with control.
- The bundle combined 10-minute prewarming, forced-air warming during and after surgery, a room kept at 21 °C, and fluids warmed to 38 °C.
- At surgery start, hypothermia occurred in 1.3% vs 9.9% of controls (OR 7.59, P=0.021), and at PACU admission in 14.3% vs 29.6% (OR 2.07, P=0.024).
- Wound infections requiring readmission were not significantly reduced (OR 0.35, 95% CI 0.04 to 2.92, P=0.332); presurgery stay and OR/PACU occupancy were SSI risk factors.